Brief: Diamyd Medical Resolves On Rights Issue Of SEK 163 Million

Diamyd Medical AB

24/05/2023 08:07

May 24 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * DIAMYD MEDICAL RESOLVES ON A RIGHTS ISSUE OF SHARES OF
APPROXIMATELY SEK 163 MILLION AND CONVENES AN EGM TO RESOLVE ON
AN ISSUE OF WARRANTS AND AMENDMENT OF THE ARTICLES OF
ASSOCIATION
    * SUBSCRIPTION PRICE IN RIGHTS ISSUE HAS BEEN SET TO SEK
8.50 PER
SHARE
    * TO PROPOSE THAT SUBSCRIBERS OF SHARES SHOULD RECEIVE
WARRANTS
FREE OF CHARGE
    * WILL USE ABOUT 70%  OF PROCEEDS FOR CLINICAL DEVELOPMENT
OF
DIAMYD, PRIMARILY FOR DIAGNODE-3
    * WILL USE REMAINING PROCEEDS FOR CONTINUED DEVELOPMENT OF
COMPANY'S PRODUCTION FACILITY IN UMEÅ, GENERAL ADMINISTRATION
AND OTHER

Source text for Eikon:  ID:nWkr9tpMTJ 
Further company coverage:  DMYDb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))